Zimbabwe approves long-acting HIV prevention drug
Zimbabwe has become the first county in Africa to approve a long-acting injectable drug that prevents HIV transmission. The first two injections of Cabotegraviror CAB-LA are administered four weeks apart, followed by an injection every eight weeks. The drug has received regulatory approval in two other countries, the US and Australia. Zimbabwe will begin rolling […]